NASDAQ •
Healthcare •
Medical Devices •
Quote as of 05/29/2026
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,405.79 mln
Float33.45 mln
Earnings Date07/30/2026
EPS
4.37
Solid
P / E
15.36
Moderately valued
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-0.83
Highly suspicious
1-Year Forecast
118
Transformational upside
Relative Strength
84
/ 100
Strongly outperforming
Business Description
TransMedics Group develops and sells technology that helps keep donor organs healthy outside the human body while they are being transported for transplant surgery. Their main product is the Organ Care System, a portable device that maintains near-natural conditions for donor hearts, lungs, and livers, giving doctors more time and flexibility during the transplant process. The company also runs a managed service that handles the full logistics of organ retrieval and delivery, including air and ground transportation. Founded in 1998 and based in Andover, Massachusetts, TransMedics operates across the United States and in other countries.
